Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00494546 · ClinicalTrials.gov registry record · Phase 3
High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer
A Phase 3 study, sponsored by VA Puget Sound Health Care System.
- Completed
- Registry status
- Phase 3
- Development phase
- 568
- Enrollment target
NCT00494546 is a Phase 3 study that has completed, run by VA Puget Sound Health Care System. The registered enrollment target is 568 participants.
The verdict
NCT00494546, a Phase 3 study, has completed, sponsored by VA Puget Sound Health Care System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 568 participants
- Enrollment target
Study Summary
Objective: The objective of this study is test the hypothesis that delivering a higher percentage of the radiation dose as external radiation versus implant will lead to higher tumor control rates. Research design A total of 600 patients with AJC clinical stage T1-T2 prostatic carcinoma (Gleason grade 7 to 10 and/or PSA 10 to 20 ng/ml) will be randomized to treatment with 44 Gy versus 20 Gy external radiation plus a Pd-103 implant boost (90 Gy versus 105 Gy, respectively).
Interventions
- PROCEDURE Pd-103 with 20 vs 44 Gy supplemental beam XRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 568 participants |
| Start Date | 1999-01 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00494546
The ClinicalTrials.gov registry entry for NCT00494546 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 568 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Puget Sound Health Care System, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pd-103 with 20 vs 44 Gy supplemental beam XRT is the first listed.
NCT00494546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00494546 about?
NCT00494546 is a clinical study titled "High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer". Objective: The objective of this study is test the hypothesis that delivering a higher percentage of the radiation dose as external radiation versus implant will lead to higher tumor control rates. Research design A total of 600 patients with AJC clinical stage T1-T2 prostatic carcinoma (Gleason gr...
What is the current status of trial NCT00494546?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 568 participants. The study started on 1999-01. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00494546?
The interventions under investigation include: Pd-103 with 20 vs 44 Gy supplemental beam XRT (PROCEDURE).
Who is sponsoring clinical trial NCT00494546?
This trial is sponsored by VA Puget Sound Health Care System, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.